Free Trial

Evofem Biosciences (EVFM) SEC Filings & 10K Form

Evofem Biosciences logo
$0.01 0.00 (0.00%)
(As of 11/20/2024 ET)

Recent Evofem Biosciences SEC Filings

DateFilerForm TypeView
11/14/2024
4:18 PM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:05 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
4:20 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
7:15 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:36 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:15 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:48 PM
Evofem Biosciences (Filer)
Form PRE 14A
08/30/2024
4:04 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
11:11 AM
Evofem Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
08/14/2024
6:00 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:05 AM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
3:30 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:35 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:15 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:46 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
5:45 AM
Evofem Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
5:50 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:28 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:36 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:40 AM
Evofem Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:14 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:14 PM
CVI Investments, Inc. (Filed by)
Evofem Biosciences (Subject)
Form SC 13G/A
02/01/2024
8:05 AM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:26 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
4:13 PM
Evofem Biosciences (Issuer)
Zhang Yan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:53 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:05 PM
Evofem Biosciences (Issuer)
Kamdar Kim P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:17 PM
Evofem Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EVFM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners